LeMaitre to Participate at Upcoming Investor Conferences in November
03 Nov 2023
BURLINGTON, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming investor conferences in November.
Jefferies London Healthcare Conference
Tuesday, November 14, 2023
London, UK
JJ Pellegrino, Chief Financial Officer, will present at 11:00 AM GMT
Stifel's 2023 Healthcare Conference
Tuesday, November 14, 2023
Lotte NY Palace Hotel, New York City
David Roberts, President, will present at 1:50 PM ET
Piper Sandler 35th Annual Healthcare Conference
Wednesday, November 29, 2023
Lotte NY Palace Hotel, New York City
David Roberts, President, will present at 2:10 PM ET
About LeMaitre
LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at
Contact:
LeMaitre Vascular, Inc.
Sandra Millar
+1-781-425-1686
smillar@lemaitre.com
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.